Clinical Trial Update: A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase IIIb trial comparing intermittent versus continuous hormone deprivation therapy with ELIGARD (goserelin) in prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Eligard (leuprolide acetate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED